

About Us
We offer a full suite of interim management, consulting, advisory, business/corporate development, and project management services to biotechnology, pharmaceutical and cannabis companies, or to other organizations with an interest in the life science sector. We also assist international organizations in creating a presence or operations in Canada, and can provide business development representation for North American markets. In addition, we work with academic institutions and entrepreneurs with start-up company formation and investor readiness.
​
Other Services for Cannabis Companies:
• Cannabis product portfolio strategy and assessment: profitability, competitiveness, differentiation etc.
• Cannabis/cannabinoid product development from idea to market launch, shelf-life determination.
• Identifying, evaluating and securing external technology and new product opportunities.
We look forward to learning about your needs and building a relationship.
Our Expertise
-
Strategic planning, innovation strategy
-
Business plans, investor presentations
-
Financing strategy
-
Opportunity identification & assessment
-
Due diligence, competitive intelligence
-
In-licensing & out-licensing
-
Partnership agreements
-
Managing drug discovery and preclinical drug development
-
Managing partnerships, alliances, CROs, CMOs
-
Leading cross-functional teams
-
Leading/managing multi-stakeholder academic and innovation initiatives
-
Intellectual property management
-
Drafting patent applications
-
Medical/scientific writing including SR&ED claim submissions and grant writing
-
Building teams
Principal Consultant
Robert Foldes has spent his entire 25+ year career in the life science sector. He has worked with start-up, emerging and large biotechnology firms, specialty pharmaceutical companies, legal cannabis companies, and leading teaching hospitals & research institutes. He provides a unique perspective that bridges industry and academia, business and science. Robert has consulted for organizations with an interest in the life science sector since 2005.
In his career, Robert has served as CEO of Cytochroma Inc., and Viteava Pharmaceuticals Inc., VP Product Development at VIVO Cannabis Inc., and held senior business development roles at The Hospital for Sick Children and Allelix Biopharmaceuticals Inc. He holds a PhD in Pharmacology from the University of Nebraska Medical Center and an MBA from the Schulich School of Business. He resides in Toronto, Canada.
Connect with Us
WE ADAPT TO YOUR NEEDS, BUDGETS, TIME FRAMES AND CULTURE. PROJECTS OF ALL SIZES AND DURATIONS ARE WELCOME. WE ARE HERE TO HELP.
​‹EMAIL:
​
FOLLOW US: